Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
iZafe Group AB (publ) operates as a life sciences firm dedicated to creating, advancing, and marketing digital medical solutions and services. Its core objective is to enhance the safety of medication management for individuals in their homes. A flagship offering is Dosell, an automated dispenser designed to manage pre-packaged dose bags. This device not only empowers users to self-administer their medication but also provides crucial reminders and alerts if a dose is missed. The company's customer base is broad, encompassing individual consumers as well as public and private healthcare providers across Sweden, the wider Nordic region, and international markets. Founded in 2008, the company initially operated under the name MediRätt AB (publ) before officially rebranding to iZafe Group AB (publ) in May 2019. Its corporate headquarters are situated in Stockholm, Sweden.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.